Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 2712
  • Home
  • Print this page
  • Email this page
BRIEF COMMUNICATION
Year : 2011  |  Volume : 59  |  Issue : 4  |  Page : 318-319

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis


Department of Cornea and Anterior Segment, The Eye Super Specialities, Ghatkopar - East, Mumbai - 400 077, India

Correspondence Address:
Urmi N Shah
Cornea and Anterior Segment Consultant, The Eye Super Specialities, 201, Punit Plaza, Next to Rajawadi Post Office, Ghatkopar (E), Mumbai - 400 077
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.82005

Rights and Permissions

The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2152    
    Printed31    
    Emailed0    
    PDF Downloaded198    
    Comments [Add]    

Recommend this journal